Twitter Telegram

LATEST NEWS!

Donate

Post

Misleading claims by Popp et al. in BMJ Journal

Rapid Response to Editor of BMJ Evidence Based Medicine

Re: Popp M, Kranke P, Meybohm P, et al. Evidence on the efficacy of ivermectin for COVID-

19: another story of apples and oranges. BMJ Evidence-Based Medicine Published Online

First: 20 August 2021. doi: 10.1136/bmjebm-2021-111791

Andrew Bryant MSc

Population Health Sciences Institute, Newcastle University

Theresa A Lawrie MBBCh PhD 

Edmund J Fordham PhDFInstP

EbMCsquared CIC

To the Editor

The integrity of our meta-analyses of trial data on Ivermectin for prevention and treatment of Covid-19 is questioned by authors of a recent Cochrane review. We agree that misleading information on Covid-19 treatment abounds in social and mainstream media as well as in journal opinion pieces. However, Bryant et al is a non-commissioned research paper that strictly followed PRISMA systematic review guidelines.

Download pdf

Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.

Share:

Telegram
Twitter

Transparency Statement: The team at Bird are transparent in our operations.  Bird is a campaign managed through EbMCsquared, a not-for-profit Community Interest Company.  It means 100% of profits after tax are reinvested into the business or to the advancement of our social purpose, for example to work on projects such as the Ivermectin campaign.  We are here to promote and provide evidence for health and wellbeing, to inform decision-making on matters of public health and safety.  We do this to advance health and wellbeing for the benefit of humankind.

Disclaimer: Nothing on this Website provides medical advice or any form of diagnosis or treatment of any kind to web users. Medical decisions should be made by the patient’s physician who can consider a review of the BIRD materials and knowledge of the patient’s medical history and condition. All information provided on the BIRD website or in connection with the Website are offered to promote consideration by trained health care professionals of possible treatments and for general informational purposes and are not medical advice to users. Errors and Omissions excepted.

Policies | To Top

© 2021 BIRD Group. All Rights Reserved

Please Contribute

Let's Get Ivermectin Approved

Safe, cheap, beats Covid

Please support our campaign with a monthly or a single amount to help us keep pressure on authorities to approve the safe drug ivermectin that will help beat covid-19 and save lives around the world.

Bird Group/EBMC Squared is a not-for-profit Community Interest Company (CIC).

All funds received will be invested in our activities to promote public health and wellbeing.

Please contribute

Your monthly or single contribution will help us keep pressure on authorities to approve the safe drug ivermectin that will help beat covid-19 and save lives around the world.